EXACT Cost Of Revenue from 2010 to 2024
| EXAS Stock | USD 55.14 2.23 4.21% |
Cost Of Revenue | First Reported 2000-03-31 | Previous Quarter 213.2 M | Current Value 196.1 M | Quarterly Volatility 55.3 M |
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.9 B or Research Development of 447.2 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
EXACT | Cost Of Revenue |
Latest EXACT Sciences' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of EXACT Sciences over the last few years. Cost of Revenue is found on EXACT Sciences income statement and represents the costs associated with goods and services EXACT Sciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is EXACT Sciences' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
EXACT Cost Of Revenue Regression Statistics
| Arithmetic Mean | 221,433,817 | |
| Coefficient Of Variation | 114.87 | |
| Mean Deviation | 216,201,909 | |
| Median | 79,196,000 | |
| Standard Deviation | 254,358,499 | |
| Sample Variance | 64698.2T | |
| Range | 687.4M | |
| R-Value | 0.91 | |
| Mean Square Error | 12119.8T | |
| R-Squared | 0.83 | |
| Slope | 51,693,417 | |
| Total Sum of Squares | 905775.4T |
EXACT Cost Of Revenue History
About EXACT Sciences Financial Statements
EXACT Sciences shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 654.2 M | 687 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.